Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIVAROXABAN vs RIZATRIPTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIVAROXABAN vs RIZATRIPTAN: Safety Overview

Metric RIVAROXABAN RIZATRIPTAN
Total FAERS Reports 131,274 2,896
Deaths Reported 19,233 68
Death Rate 14.7% 2.3%
Hospitalizations 70,513 479
Average Patient Age 70.0 yrs 44.6 yrs
% Female Patients 47.7% 77.2%
FDA Approval Date Apr 10, 2025 Apr 14, 2023
Manufacturer Macleods Pharmaceuticals Limited Panacea Biotec Limited
Route ORAL ORAL
Marketing Status Prescription Discontinued